Crohn’s & Colitis Foundation Perspectives
As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s & Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis.
With 1.6 million Americans living with IBD, which includes Crohn’s disease and ulcerative colitis, and approximately 70,000 new cases diagnosed annually, the Crohn’s & Colitis Foundation is dedicated to developing and cultivating IBD healthcare providers through continued education and creation of valuable resources that directly impact the standard-of-care and everyday clinical practices in IBD.
The Crohn’s & Colitis Foundation is the only national organization dedicated to driving efforts in IBD research, education and support for patients, caregivers, and professionals. The Crohn’s & Colitis Foundation is building initiatives to address high priority areas, and developing the tools, including this educational series, to educate healthcare professionals and meet patients’ needs.
In Collaboration with
Episodes 1-16 of 30
Ross M. Maltz, MD
Shail M. Govani, MD, MSc
Nana E. Bernasko, CRNP, WHNP-BC, DNP
Shubha Bhat, PharmD, MS, BCACP
- Crohn’s & Colitis Foundation Perspectives
Crohn’s & Colitis Congress 2022: A Look at Diet & Nutrition Therapies
Jennifer Caudle, DO
Maitreyi Raman , MD, MSc, FRCPC
- Crohn’s & Colitis Foundation Perspectives
Crohn's & Colitis Congress 2022: Looking Back & Looking Ahead with the 2023 Chair
Charles Turck, PharmD, BCPS, BCCCP
Peter D. Higgins, MD, PhD
- Crohn’s & Colitis Foundation Perspectives
Crohn's & Colitis Congress 2022: Improving Moderate Ulcerative Colitis Care
Jennifer Caudle, DO
Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI
- Crohn’s & Colitis Foundation Perspectives
Exploring the DINE-CD Study & the Importance of Diet for IBD Patients
Peter Buch, MD, FACG, AGAF, FACP
Caren Heller, MD, MBA
- Crohn’s & Colitis Foundation Perspectives
Endoscopic & Histological Assessment, Correlation, & Relapse in Clinically Quiescent Ulcerative Colitis
Jordan E. Axelrad, MD, MPH
- Crohn’s & Colitis Foundation Perspectives
Keeping CALM in Crohn’s Disease: An Exploration of Biomarker Cutoffs & Endoscopic Outcomes
Xiaohong Wang, MD, PhD
- Crohn’s & Colitis Foundation Perspectives
Crohn’s & Colitis Congress 2021: Getting a Holistic View of IBD Diet Disparities & Well-Being
Tina Aswani Omprakash
- Crohn’s & Colitis Foundation Perspectives
Crohn’s & Colitis Congress 2021: Challenges & Approaches to Managing IBD in the COVID-19 Era
Charles Turck, PharmD, BCPS, BCCCP
Frank Scott
- Crohn’s & Colitis Foundation Perspectives
Crohn’s & Colitis Congress 2021: The Future of IBD Treatments
Charles Turck, PharmD, BCPS, BCCCP
Siddharth Singh, MD
- Crohn’s & Colitis Foundation Perspectives
Crohn’s & Colitis Congress 2021: Incorporating IBD Therapies
Charles Turck, PharmD, BCPS, BCCCP
Stephen Hanauer, MD
- Crohn’s & Colitis Foundation Perspectives
Crohn’s & Colitis Congress 2021: Caring for Children with IBD Amid the Pandemic
Charles Turck, PharmD, BCPS, BCCCP
Michael D. Kappelman, MD, MPH
- Crohn’s & Colitis Foundation Perspectives
Crohn’s & Colitis Congress 2021: Assessing the Role of Immunomodulators in IBD
Charles Turck, PharmD, BCPS, BCCCP
Maria M. Oliva-Hemker, MD
- Crohn’s & Colitis Foundation Perspectives
Crohn’s & Colitis Congress 2021: Making the Most of IBD Treatment
Charles Turck, PharmD, BCPS, BCCCP
Marla C Dubinsky, MD
- Crohn’s & Colitis Foundation Perspectives
Exploring the Role of Cannabis in Inflammatory Bowel Disease
Shira Johnson, MD
Arun Swaminath, MD
Stacy Kahn, MD
Jessica Allegretti, MD, MPH
- Prev
- Next